🔗 Share this article

An underground market for unapproved weight-loss medications is being driven by social media fitness personalities and vendors on messaging platforms, based on new investigations.

Experimental Treatment Gaining Traction Online

Retatrutide, which is still in clinical trials, is being promoted by online personalities for its supposed fat-burning effects. Followers are urged to contact these accounts directly for supplier links, while also obtaining promotional offers.

Active Commerce on Social Networks

Separately, a robust market exists on messaging services, where groups with thousands of members share “before and after” images, administration instructions and assertions of rapid UK delivery. Vendors promote the substance there before redirecting buyers to WhatsApp for purchases.

Understanding Retatrutide

Retatrutide is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.

Healthcare Professionals Voice Concerns

However, doctors and chemists have warned that the sale of what is still an unapproved drug in the UK is a cause for concern and could result in users administering substances of unknown origin.

Some experts stated the popularity for the experimental drug could be linked to the increasing price of licensed weight loss treatments such as Mounjaro.

Regulatory Status and Enforcement

Selling retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that must not be marketed or supplied for human use under the British medical regulations.

Some content creators try to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still breach medicines, marketing, and consumer laws, risking penalties, legal action or imprisonment.

Platform Reaction and Material Removal

According to TikTok, the service has removed violative material and banned associated hashtags and query recommendations. The organization said it was committed to keeping the platform safe and allocating resources in enhancing enforcement strategies.

Digital Trading Activities

Research also found communities with up to 9,000 members marketing the experimental drug using the platform's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” instantly displays channels with thousands of users, populated with photos of slimming results, glowing reviews and step-by-step guides for mixing or administering at home.

After minutes of entering one community, a seller posted contact information, where the majority of purchases take place. The seller sent an guidebook and promised delivery within 48 hours. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one asked about weight, medical conditions or previous experience.

Product Information and Costs

Within these groups, messages display dark colored packages with Royal Mail stickers, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at residence with sterile water, or ready-to-use injectors usually priced at £160 for 20 milligrams. When asked how much time a pen should last, sellers give contradictory answers varying between a few weeks to “depends on your body”.

Service Moderation and Safety Actions

A spokesperson for the messaging service said it regularly monitored dangerous material on its service including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are administering substances they can’t verify. Although the research behind retatrutide is sound, these online products may not include what they claim,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor connected the increase in demand to current cost increases for authorized weight-loss medications such as Mounjaro. “With prices rising, patients are turning to social media. But counterfeit injections are extremely risky. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she said.

Her staff has previously seen patients injured by self-injection from unconfirmed sources. “We recognize the frustration, but buying from Telegram or WhatsApp is gambling with your health,” said Wyllie. “These materials could be contaminated or improperly measured.”

Producer Position

A spokesperson from Eli Lilly said retatrutide was in third stage clinical trials and had not been reviewed or authorized by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they said, noting that any item “misleadingly claiming itself as a Lilly experimental substance not yet approved … may subject users to potentially serious medical dangers”.